TBPH
NASDAQ
$16.81
Theravance Biopharma Inc (TBPH)
Theravance Biopharma, Inc., a diversified biopharmaceutical company, discovers, develops, and markets organ-selective drugs in the United States, Europe, and Asia. The company is headquartered in George Town, the Cayman Islands.
Sector:
Healthcare
Industry:
Biotechnology
Hold
Target: $17.67 (+5.12%)
Market Cap
$872M
Forward P/E
7.91
P/E Ratio
12.26
Free Cash Flow Yield
30.82%
Price Chart
Valuation
Market Cap$872M
P/E12.26
Forward P/E7.91
P/S7.99
P/B3.01
Profitability
Total Revenue (TTM)$110M
Gross Profit (TTM)$78M
EBITDA$4.92M
Profit Margin-27.9%
Operating Margin-53.6%
EPS$1.38
Financial Health
Free Cash Flow Yield30.82%
Growth & Risk
Revenue 5Y CAGR+10.63%
Beta (5Y)0.53
Sharpe Ratio0.96